Literature DB >> 27342269

Evaluation of anti-inflammatory, analgesic activities, and side effects of some pyrazole derivatives.

Souraya Domiati1, Ahmed El-Mallah2, Asser Ghoneim3, Adnan Bekhit4, Heba Abd El Razik4.   

Abstract

BACKGROUND AND
PURPOSE: Non-steroidal anti-inflammatory drugs are associated with several side effects, such as gastrointestinal mucosal damage, renal toxicity, and cardiovascular side effects. Aiming to find a novel analgesic/anti-inflammatory drug with minimal side effects, the present study was designed to screen and evaluate some newly synthesized pyrazole derivatives.
METHOD: Anti-inflammatory activity using carrageenan-induced rat paw edema and cotton-pellet-induced granuloma, COX-1/COX-2 selectivity using thin layer chromatography, and analgesic using hot plate and tail flick tests as well as ulcerogenic and renal side effects of the ten compounds were assessed. RESULTS AND DISCUSSION: The results of the carrageenan-induced rat paw edema showed that the carboxyphenylhydrazone derivative (N9) was more potent than the chlorophenyl counterpart (N8) with a relative activity compared to celecoxib of 1.08 and -0.13, respectively, after 1 h. Even though this is true, N9 caused significant increase in the ulcer index, creatinine, and Blood Urea Nitrogen levels. The cotton granuloma test showed that the carboxyphenylhydrazone derivative (N7) was also more potent than its chlorophenyl counterpart (N6) with a relative activity compared to celecoxib of 1.13 and 0.86, respectively. Moreover, adding an acetyl not only increased the anti-inflammatory activity from a relative activity compared to celecoxib of 0.57-1.17 for the compounds X4 and N5, respectively, in the granuloma test, but also increased the selectivity toward COX-2 from 0.197 to 47.979.
CONCLUSION: As a conclusion, from the ten compounds analyzed, N5 and N7 showed promising results as anti-inflammatory/analgesic agents with low ulcerogenicity and nephrotoxicity and thus should be further analyzed to determine the ED50 and other side effects.

Entities:  

Keywords:  Cyclooxygenase; Inflammation; Non-steroidal anti-inflammatory drugs; Pyrazole derivatives

Mesh:

Substances:

Year:  2016        PMID: 27342269     DOI: 10.1007/s10787-016-0270-7

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  24 in total

Review 1.  Animal models of nociception.

Authors:  D Le Bars; M Gozariu; S W Cadden
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 25.468

2.  Topical Nonsteroidal Anti-Inflammatory Drugs: The Importance of Drug, Delivery, and Therapeutic Outcome.

Authors:  Robert L Barkin
Journal:  Am J Ther       Date:  2015 Sep-Oct       Impact factor: 2.688

3.  A novel COX-2 inhibitor pyrazole derivative proven effective as an anti-inflammatory and analgesic drug.

Authors:  Mahmoud M Mohy El-Din; Amira M Senbel; Azza A Bistawroos; Ahmed El-Mallah; Nour A Nour El-Din; Adnan A Bekhit; Heba A Abd El Razik
Journal:  Basic Clin Pharmacol Toxicol       Date:  2010-12-08       Impact factor: 4.080

Review 4.  Nonsteroidal anti-inflammatory drugs: effects on kidney function.

Authors:  A Whelton; C W Hamilton
Journal:  J Clin Pharmacol       Date:  1991-07       Impact factor: 3.126

Review 5.  Inflammation and the mechanism of action of anti-inflammatory drugs.

Authors:  J Vane; R Botting
Journal:  FASEB J       Date:  1987-08       Impact factor: 5.191

6.  [Celecoxib vs indomethacin and acute gastric lesions in rats].

Authors:  O M Laudanno; J M Esnarriaga; J A Cesolari; C B Maglione; L J Aramberry; J S Sambrano; G Piombo; L Rista
Journal:  Medicina (B Aires)       Date:  2000       Impact factor: 0.653

7.  Effect of nonsteroidal anti-inflammatory drugs with varying extent of COX-2-COX-1 selectivity on urinary sodium and potassium excretion in the rat.

Authors:  Sam Harirforoosh; Fakhreddin Jamali
Journal:  Can J Physiol Pharmacol       Date:  2005-01       Impact factor: 2.273

8.  Central components of the analgesic/antihyperalgesic effect of nimesulide: studies in animal models of pain and hyperalgesia.

Authors:  Cristina Tassorelli; Rosaria Greco; Giorgio Sandrini; Giuseppe Nappi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Improved antiulcer and anticancer properties of a trans-resveratrol analog in mice.

Authors:  Prasun Guha; Anindya Dey; Biswanath Sarkar; Manish V Dhyani; Subrata Chattopadhyay; Sandip K Bandyopadhyay
Journal:  J Pharmacol Exp Ther       Date:  2008-12-09       Impact factor: 4.030

10.  Enhancement of antinociception by coadministration of minocycline and a non-steroidal anti-inflammatory drug indomethacin in naïve mice and murine models of LPS-induced thermal hyperalgesia and monoarthritis.

Authors:  Ala'a Ahmed Abu-Ghefreh; Willias Masocha
Journal:  BMC Musculoskelet Disord       Date:  2010-12-01       Impact factor: 2.362

View more
  5 in total

1.  Antiedematogenic and Anti-Inflammatory Activity of the Monoterpene Isopulegol and Its β-Cyclodextrin (β-CD) Inclusion Complex in Animal Inflammation Models.

Authors:  Andreza Guedes Barbosa Ramos; Irwin Rose Alencar de Menezes; Maria Sanádia Alexandre da Silva; Renata Torres Pessoa; Luiz Jardelino de Lacerda Neto; Fabíola Rocha Santos Passos; Henrique Douglas Melo Coutinho; Marcello Iriti; Lucindo José Quintans-Júnior
Journal:  Foods       Date:  2020-05-14

Review 2.  Regulation of Autophagy by Non-Steroidal Anti-Inflammatory Drugs in Cancer.

Authors:  Xiangjie Fu; Tan Tan; Peijun Liu
Journal:  Cancer Manag Res       Date:  2020-06-16       Impact factor: 3.989

3.  Designing, synthesis and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4,5-dihydro-pyrazol-1-yl]benzenesulfonamides.

Authors:  Halise Inci Gul; Ebru Mete; Sakip Emre Eren; Hiroshi Sakagami; Cem Yamali; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2016-10-23       Impact factor: 5.051

4.  Anti-inflammatory activity of Tetragronula species from Indonesia.

Authors:  Muhamad Sahlan; Andrea Devina; Diah Kartika Pratami; Herbert Situmorang; Siti Farida; Abdul Munim; Benyamin Kusumoputro; Masafumi Yohda; Ahmad Faried; Misri Gozan; Mia Ledyawati
Journal:  Saudi J Biol Sci       Date:  2018-12-17       Impact factor: 4.219

5.  Synthesis, 3D-QSAR, and Molecular Modeling Studies of Triazole Bearing Compounds as a Promising Scaffold for Cyclooxygenase-2 Inhibition.

Authors:  Ranza Elrayess; Mohamed Saleh Elgawish; Marwa Elewa; Mohamed S Nafie; Sameh S Elhady; Asmaa S A Yassen
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.